Maven Securities’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Maven Securities's ABUS Position: Q3 2026 in Review
Maven Securities opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 100,000 shares worth $478K. The stake represents 0.01% of the portfolio and ranks #393 among its holdings. This is a return to the name: Maven Securities previously reported a position in ABUS as recently as Q1 2021.
Maven Securities first reported a position in ABUS in Q1 2021 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Maven Securities held 100,000 shares of Arbutus Biopharma worth $478K as of Q3 2026.
- Arbutus Biopharma was a new Maven Securities position in Q3 2026.
- Arbutus Biopharma made up 0.01% of Maven Securities's portfolio in Q3 2026, its #393 holding.
- Maven Securities first reported a position in Arbutus Biopharma in Q1 2021 and has held it in 2 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Maven Securities's 13F filing for Q3 2026, filed 13 Nov 2026.